HPB & Spleen · 14 May 2024

Impact of Conversion Surgery on Patients Responding to Immunotherapy for Unresectable Biliary Tract Cancer

Conversion surgery significantly improves survival outcomes in patients with positive responses to PD-1/PD-L1 inhibitor-based combined therapy for unresectable biliary tract cancer. Median progression-free survival and overall survival were significantly longer with conversion surgery compared to continued systemic therapy alone. The estimated 3-year survival rates post-surgery are promising, highlighting the potential benefits of this intervention in this patient population.

Journal Article by Wang S, Wang Y (…) Zhao H et 12 al. in Int J Surg

read the whole article in Int J Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Surg Endosc6 Nov 2026

A new cut for robotic liver surgery

A close-to-open cutting method was used for robotic liver resection, with no bile leaks and shorter hospital stays than after laparoscopy.

Surg Endosc6 Nov 2026

Robotic liver resection with short-pitch dividing shortens hospital stay

Robotic liver resection using a close-to-open forceps technique was associated with no bile leakage and a shorter hospital stay than laparoscopic resection, even though more complex resections were performed in the robotic group.

Surg Endosc6 Nov 2026

Robotic bile duct stone surgery: fewer complications

Removing large common bile duct stones with a robot rather than laparoscopically was linked to fewer complications and shorter hospital stays, at a higher cost, in a study from one Chinese hospital.

All papers in HPB & Spleen →